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The CVP (Coriolus versicolor polysaccharide) is well known as anti-tumor drug in clinical applications. 
Although recent studies have demonstrated that CVP can inhibit the proliferation of cancer cells in vitro 
and in vivo, the different purity level of CVP has a different affect on various cancer cells. In this study, 
the crude CVP was extracted from C. versicolor dry fruit bodies by hot-water extraction and ethanol 
precipitation. The content of CVP was 7.74% in the fruit bodies, while 54.69% in the crude extracts by 
phenol-vitriolic colorimetry. After that, the in vitro cytotoxic activities of the CVP were examined on the 
four human liver cancer (7703, HepG2, 7721, PLC) and four human breast cancer (Bcap37, ZR75-30, 
MCF-7, T-47D) cell lines using a MTT cytotoxicity assay. The results showed that the CVP inhibited the 
proliferation of 7703, Bcap37, T-47D in low concentration; the IC50 values on 7703, Bcap37 and T-47D 
were 18.37, 14.42 and 9.29 mg/l, respectively. The CVP also inhibited the proliferation of MCF-7 and 
ZR75-30, but at high concentration, the IC50 values on MCF-7 and ZR75-30 were 39.26 and 34.59 mg/l, 
respectively. The CVP does not inhibit the proliferation of HepG2, 7721, PLC and human normal liver 
cell line (WRL). The CVP was found to selectively inhibit the proliferation of human liver cancer and 
human breast cancer. 
 





Coriolus versicolor, also known as Yun Zhi (YZ), belong-
ing to the family Basidiomycotina, is a mushroom widely 
used in traditional Chinese herbal remedies. Its medical 
value correlate to C. versicolor extracts. Of the C. 
versicolor-derived therapeutics extracts, polysaccharo-
peptides are commercially the best established. The  
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polysaccharopeptides were obtained from C. versicolor 
known as C. versicolor polysaccharides (CVP), is a com-
plicated protein-bound polysaccharide extracted from its 
mycelium or fruiting body. The composition of the 
polysaccharopeptide appears to depend on the source of 
the material and the method of recovery used, such as 
polysaccharopeptide Krestin (PSK) obtained from the 
extraction of C. versicolor (CM-101) strains in China and 
polysaccharopeptide (PSP) obtained from the extraction 
of C. versicolor (Cov-1) strains in Japan. Both products 
have similar physiological activities but are structurally 
different (Chu et al., 2002). The major bioactive CVP is a 
-(13)-glucan branching at 4’ and 6’ positions. The 





cose units; the main chain of -1-3 consisted of -D-1, 4-
Glc and -D-1, 3-Glc, and branch chains were situated, 
-D-1, 3, 6-Glc and -D-1, 4, 6-Glc (Zhang et al., 2001). 
The substance contained a branched glucan core with 
(13)--, (14)-- and/or (16)--linkages, has a 
molecular weight of about 100 KDa and is highly water-
soluble (Ng, 1998; Wang et al., 1996).  
The CVP have many pharmacological activities, includ-
ing immunopotentiation, immunosuppressive, improve-
ment of appetite and liver function, calming of the central 
nervous system and enhancement of pain threshold. 
Historically, the CVP have been considered as important 
remedies for maintaining health, enhancing overall 
immune status, and prevention and treatment of chronic 
diseases (Ng, 1998). Presently, CVP is considered as a 
potential candidate for drug development in treatment 
and prevention of human cancers because of its 
immunological properties as well as its ability to 
distinguish cancerous cells from normal cells. Based on a 
statistics and analysis of anti-tumor plant drugs in a 
hospital of Guangdong province, the frequency of using 
CVP is the highest in various fungal polysaccharides 
during the years of 2000-2002 (Liu et al., 2005). In vitro 
studies reveal that PSP acts selectively on B-cell 
lymphoma cell line (Raji), human promyelocytic leukemia 
cell lines (HL-60, NB-4) (Lau et al., 2004; Hsieh et al., 
2002), human breast cancer cell lines (T-47D, MCF-7, 
MDA-MB-231) (Aoyagi et al., 1997; Chow et al., 2003), 
prostate cancer cell lines (PC-3, DU-145) (Hsieh and Wu, 
2001). Although the CVP suppress proliferation of many 
human cancer cell lines in vitro and in vivo, not all 
cancers seem to respond to C. versicolor 
polysaccharopeptides. Normal lymphocytes, human 
normal liver cell line (WRL) and human breast cancer cell 
line (BT20) are not affected by PSP (Hsieh et al., 2002; 
Lau et al., 2004; Ho et al., 2005). The anti-tumor activity 
of the extract from C. versicolor appears to depend on 
the strains-derived (Yang et al., 2000), the habitat in 
which it grows (Monro, 2003), the source material 
(Matsunaga et al., 1996) and the method of recovery 
used (Chen et al., 2003). The CVP can be produced from 
C. versicolor mushrooms harvested in the wild or 
cultivated commercially or from mycelial growth of C. 
versicolor in submerged fermentation. The 
polysaccharopeptides isolated from different sources 
(mushroom, mycelium, and biomass-free broth) differ 
somewhat in structure, composition, and physiological 
activity. The present study aimed to examine the in vitro 
cytotoxic activities of a culture-grown of C. versicolor hot-
water extract in eight cell lines and to verify if the crude 
CVP can be extracted from the fruit body. This study 
provides a method of extract prepared CVP from 
cultivated fruit bodies, and farther revealed that the CVP 
significantly suppressed the proliferation of four human 
breast cancer cells in a dose-dependent manner, and 
four human liver cancer cells in a selectively manner in 
vitro. 








The cells used were human liver cancer cell lines (7703, HepG2, 
7721, PLC), human breast cancer cell lines (Bcap37, ZR75-30, 
MCF-7, T-47D) and human normal liver cell line (WRL) provided by 
the Cancer Institute of Shanghai Jiao Tong University. The RPMI-
1640 medium and fetal calf serums were purchased from the Gibco 
Laboratories (Grand Island, NY, USA). The MTT (3-(4, 5-
dimethylthiazolyl)-2, 5-diphenyl-tetrazolium bromide) and the 
dimethyl sulfoxide (Me2SO) were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Other chemicals used were reagent 
grade which were purchased from local chemical agent store. 
 
 
Preparation of C. versicolor extract 
 
C. versicolor fruiting bodies were cultivated by Shaanxi Key 
Laboratory of Bio-Resources, Shaanxi University of Technology 
(Zhou and Lin, 1999). The polysaccharides were obtained from the 
cultivated fruit bodies. The crude polysaccharide was extracted 
according to the method described as follows: the fruiting bodies 
were selected, cleaned, quantified and crushed. Based on a Soxh-
let extraction method with petroleum ether as the extractive solvent, 
the materials was degreased, the residual was air-dried, and then 
extracted with hot-water at proper proportion and temperature. After 
being filtrated and discolored, the solution was concentrated to 10% 
of its original volume using reduced pressure method, followed by 
precipitation with 95% ethanol. The free proteins and pigment of the 
extracts were removed by Sevage method and active carbon, and 
then the extract was refined. The major components of the extract 
are polysaccharides, the amount of which were measured and 
extracting rate was calculated by following formula: 
 
Dry-weight of ethanol sediments
Polysaccharides extracting rate=
Dry-weight of fruit bodies
 
  
The experiment was replicated three times (Tian et al., 2003). 
 
 
Determination of polysaccharide content 
 
The contents of polysaccharides were measured by the phenol-
sulphuric acid method using glucose as standard (Cuesta et al., 
2003). The basic protocol was followed, with the modifications 
indicated below. The sugar solution (2 ml) and the phenol solution 
(2 ml) were added to each screw cap tube (18 × 180 mm), which 
was capped and vortex-stirred. Then 10 ml of concentrated sulfuric 
acid was added slowly down along the side of the tube. The tubes 
were then closed, vortex-stirred for 5 s and incubated for 2 min at 
100oC water bath. All tubes were allowed to cool down to room 
temperature before measuring the absorbance at 490 nm using 
distilled water as blank in the Multiskan Spectrum Microplate Spec-
trophotometer (Thermo Labsystem). 
 
 
Cytotoxicity assays   
 
Cells were maintained as monolayer cultures in RPMI-1640 
medium supplemented with 10% fetal calf serum and incubated at 
37oC in a humidified incubator at 5% CO2. Toxicity tests were des-
cribed as before (Campling et al., 1991), nine sorts of cells were 
seeded independently in 96-well plate with the final volume 100 l 
containing 1×104 cells per well. The plates were incubated at 37oC 
for 48 h. CVP in PBS was proportionally diluted with RPMI-1640, 
and 50 l of each solution was added to triplicate wells.  After  72 h,  




0.15 mg (30 l of 5 g/l) MTT was added to each well and incubated 
at 37 oC for a further 4 h. The medium was removed and 100 l 
Me2SO was added into each well after the plate was shaken 
thoroughly for 10 min. The absorbance of the samples was mea-
sured at 570 nm with a Multiskan Spectrum Microplate Spectropho-
tometer (Thermo Labsystem). 
 
 
RESULT AND DISCUSSION 
 
Extracting and determining of CVP  
 
With hot-water extraction and ethanol precipitation, the 
content of the resulting extract (crude polysaccharide) 
from C. versicolo fruit body is about 7.74%. After free 
proteins and pigment being removed, the extract was 
refined. The content of purified polysaccharide from 
extract sample was determined as 54.69%. These results 
were consistent with previous studies (Tian et al., 2003). 
The glucose was used as standard to determine content 
of polysaccharide in the refined extracts. The results 
showed that linear concentrations, regression equation 
and regression coefficient were 0~180 g/ml, y = 
0.115+1.337X, R2 =0.99867 respectively. CVP is com-
monly recovered by precipitation from the concentrated 
extract. Ethanol precipitation (Tian et al., 2003; Kim et al., 
2001) and ammonium sulfate fractionation are used 
frequently. Conventional ion exchange chromatography 
on DEAE Sephadex and DEAE cellulose, and advanced 
HPLC methods have also been used effectively in the 
final recovery stages to purify CVP, but those are 
generally impractical in large-scale processing (Cui and 
Chisti, 2003). However, considering any commercial 
production process, the number of individual steps in the 
product recovery train should be kept to a minimum. 
Then, we select a simple and economic process for 
recovering CVP and determining the content of polysac-
charide in the extracts, which is more practical. 
 
 
Effects of CVP on the cytotoxicity of human cancer 
cells  
 
As other fungal-derived bioactive polysaccharides, the 
CVP also inhibited proliferation of intact cells (Chang, 
2002; Ebina, 2003). The CVP inhibited the proliferation of 
cancer cells of 7703, Bcap37, T-47D in low concentration; 
the IC50 of CVP on 7703, Bcap37, and T-47D were 18.37, 
14.42 and 9.29 mg/l, respectively. The CVP also inhibited 
the proliferation of cancer cells of MCF-7 and ZR75-30, 
but at high concentration, the IC50 of CVP on MCF-7 and 
ZR75-30 were 39.26 and 34.59 mg/l (Figure 1). The CVP 
does not inhibit the proliferation of cancer cells of HepG2, 
7721, PLC and human normal liver cell line (WRL). The 
study results show that the CVP can selectively and 
dose-dependently inhibit the proliferation of four breast 
cancer cell lines, with ascending order of IC50 values: T-
47D, Bcap37, ZR75-30, MCF-7, while it can only inhibit 

































Figure 1. Determination of antitumor activity and cytotoxicity of 
CVP on one human liver cancer cell lines (7703) and four 





human liver cancer cell lines (HepG2, 7721, PLC) and 
human normal liver cell line (WRL) are not affected by 
CVP. This result suggests that CVP is more actively in 
the inhibition of proliferation of human breast cancer cells 
than human liver cancer cell cells. The CV extract can 
selectively suppress the proliferation of various cell and 
cell lines are consistent with previous reports (Lau et al., 
2004; Ho et al., 2005). The recent studies demonstrated 
the in vitro anticancer mechanism(s) of CVP which 
include retardation of cancer proliferation by delaying cell 
cycle and induction of apoptosis in breast and cervical 
tumor cell lines, as well as leukemia and lymphoma cell 
lines (Ho et al., 2005). Previous research reports that 
CVP at 50 to 800 g/ml dose-dependently suppressed 
the proliferation of B-cell lymphoma (Raji) and human 
promyelocytic leukemia (HL-60, NB-4) cell lines by more 
than 90% (p<0.01), with ascending order of IC50 values: 
HL-60 (147.3 g/l), Raji (253.8 g/l) and NB-4 (269.3 g/l). 
The CVP was found to selectively and dose-dependently 
inhibit the proliferation of lymphoma and leukemic cells 
possibly via an apoptosis-dependent pathway (Lau et al., 
2004). Another research found out that the CVP dose-
dependently suppressed the proliferation of three breast 
tumor cell lines, T-47D, MCF-7, MDA-MB-231, while BT-
20 cells were not significantly affected (Ho et al., 2005). 
The anti-proliferative effects of the CVP on MDA-MB-231, 
MCF-7 and T-47D cells are mediated through apoptosis 
induction, which in turn is differentially regulated depend-
ing on p53 and Bcl-2 expression. The CVP significantly 
suppressed the proliferation of T-47D cell via up-
regulation of the p53 protein expression and down-
regulation of Bcl-2 protein expression, but in MCF-7 cell it 
is via down-regulation Bcl-2 protein expression only. But 





MDA-MB-231 cell treated with CVP. The study results 
further support the contention that CVP selectively inhi-
bits the tumor cell growth. The mechanism of action of 
the selective effect of CVP causing tumor cell death may 
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